I have not been able to post messages on this board in recent months. However, I would like to say that everyone on this board is privileged, myself included, by sharing in beneficial information posted by many sincere and informed posters. Even though I have been absent from posting, I have continued to follow most of the messages.
Recently, there have been several developments that are particularly encouraging in confirming that Anavex is pursuing what we have believed for years to be the most promising approach to treat CNS diseases that otherwise have no effective treatment. It is significant that doctors and patients have requested trial extensions, most of the Alzheimer’s trial patients are still on the drug, Anavex has meaningfully increased the inventory of its drug (suggests commercialization of its product), has added a CMC regulatory compliance person (suggests gearing up for an approval), Missling likes the idea of accelerated approval of PDD (Biostockclub, I believe, predicted that the PDD trail may lead to accelerated approval overseas), and that Anavex has the support of organizations, foundations and governments (Australia/Spain) vested and interested in seeking cures or treatments that work rather than preserving the status quo.
Anavex 2-73 will be the subject of a major publication. This came from the horse's mouth. If true, it will add credibility and fuel publicity about Anavex, which heretofore has been lacking.
Today's news, that the preferred offering has been approved is more good news that insures that our company will be around to continue its efforts. Anavex has demonstrated courage, determination and persistence in making progress that will soon force the drug industry and regulators to take notice. And the company is now in a position that it must be dealt with rather than ignored like a flea on an elephant that may be swatted into oblivion at the flick of big pharma’s tail – the passing of the preferred proposal helps send that message.
All promising news - keep up the good work. Continue to spread the word. Help for CNS disease is on the way. Anavex is coming!
